Poliomycetes Vaccine Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2022.
Poliomycetes Vaccine Market aims to provide a comprehensive presentation of the global market for Poliomycetes Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poliomycetes Vaccine. Poliomycetes Vaccine Market contains market size and forecasts of Poliomycetes Vaccine in global, including the following market information:
Global Poliomycetes Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Poliomycetes Vaccine Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Poliomycetes Vaccine companies in 2022 (%)
The global Poliomycetes Vaccine market was valued at US$ 730.3 million in 2022 and is projected to reach US$ 850.6 million by 2029, at a CAGR of 2.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Sanofi, GSK and Serum Institute are the top 3 players of Polio Vaccine with about 97% market shares.
We surveyed the Poliomycetes Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Poliomycetes Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Poliomycetes Vaccine Market Segment Percentages, by Type, 2022 (%)
Type 1
Type 2
Global Poliomycetes Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Poliomycetes Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Poliomycetes Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Poliomycetes Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Poliomycetes Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Poliomycetes Vaccine revenues share in global market, 2022 (%)
Key companies Poliomycetes Vaccine sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Poliomycetes Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi S.A
United Pharma Industries Co Ltd
Gansu Conbest Biotech Co., Ltd.
Shenzhen Mellow Hope Pharm Industrial Co., Ltd.
China National Biotec Group
Serum Institute of India
Outline of Major Chapters:
Chapter 1: Introduces the definition of Poliomycetes Vaccine, market overview.
Chapter 2: Global Poliomycetes Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Poliomycetes Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Poliomycetes Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Poliomycetes Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.